S&P 500 7,420.10 â–ŧ 91.25 (-1.21%) DOW 51,492.55 â–ŧ 507.12 (-0.98%) NASDAQ 26,021.66 â–ŧ 354.69 (-1.34%) US Markets Closed â€ĸ 04:46 AM ET

BGMS

Bio Green Med Solution, Inc.

Price Chart
Latest Quote

$0.82

-0.00 (-0.33%)
Current Price
Previous Close $0.82
Open $0.81
Day High $0.85
Day Low $0.79
Volume 155,137
Fetched: 2026-06-18T08:46:31
Stock Information
Shares Outstanding 5.52M
Cash Equivalents $3.34M
Revenue $1.52M
Net Income $-10.10M
Sector Healthcare
Industry Biotechnology
Market Cap $4.51M
P/E Ratio 0.16
EPS (TTM) $5.03
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$1.14M
Sales$1.52M
Income$-10.10M
Book/sh$1.24
Cash/sh$0.60
Financial Ratios
Quick Ratio5.69
Current Ratio7.06
Returns & Margins
ROA-49.33%
ROE20.59%
Gross Margin-34.75%
Operating Margin-31.62%
Profit Margin-204.20%
Ownership
Insider Ownership45.20%
Institutional Ownership1.79%
Insider & Institutional transactions data not available
Valuation Ratios
P/S2.96
P/B0.66
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.99
SMA50$1.00
SMA200$1.94
RSI41.61
ATR0.2593
Shares Float3.42M
Short Float0.75%
Short Ratio0.74
Rel Volume0.02
Performance History
Week-8.89%
Month-15.46%
Quarter-9.89%
6 Months-39.26%
YTD-41.84%
Year-83.92%
3 Years-99.93%
5 Years-99.99%
10 Years-100.00%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-17 $0.82 158,300
2026-06-16 $0.82 115,200
2026-06-15 $0.83 271,100
2026-06-12 $0.78 282,800
2026-06-11 $0.91 276,100
2026-06-10 $0.90 589,100
2026-06-09 $0.90 1,434,400
2026-06-08 $1.10 6,013,300
2026-06-05 $1.50 105,330,700
2026-06-04 $1.06 25,410,900
2026-06-03 $1.06 16,100
2026-06-02 $1.09 7,200
2026-06-01 $1.07 15,600
2026-05-29 $1.10 47,800
2026-05-28 $1.05 59,600
2026-05-27 $0.96 34,200
2026-05-26 $0.97 17,500
2026-05-22 $0.97 25,800
2026-05-21 $0.99 55,600
2026-05-20 $0.96 73,300
2026-05-19 $0.96 8,500
2026-05-18 $0.97 12,300
About Bio Green Med Solution, Inc.

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

📰 Latest News
No news articles available at the moment. Check back later for updates on BGMS.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $609,000 $0 - -
Cost Of Revenue $609,000 $0 - -
Total Revenue $747,000 $43,000 $420,000 $0
Operating Revenue $747,000 $43,000 $420,000 $0
Expenses
Total Expenses $9,174,000 $12,047,000 $25,873,000 $27,656,000
Other Income Expense $5,374,000 $-2,000 $-364,000 $1,531,000
Other Non Operating Income Expenses $354,000 $52,000 $50,000 $1,298,000
Net Non Operating Interest Income Expense $62,000 $12,000 $266,000 $210,000
Operating Expense $8,565,000 $12,047,000 $25,873,000 $27,656,000
General And Administrative Expense $7,717,000 $5,392,000 $6,718,000 $7,382,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-2,998,000 $-11,212,000 $-22,555,000 $-21,198,000
Net Interest Income $62,000 $12,000 $266,000 $210,000
Interest Income $62,000 $12,000 $266,000 $210,000
Normalized Income $-6,813,200 $-11,161,521 $-22,189,544 $-21,388,590
Net Income From Continuing And Discontinued Operation $-2,998,000 $-11,212,000 $-22,555,000 $-21,198,000
Total Operating Income As Reported $-8,427,000 $-12,004,000 $-25,453,000 $-27,656,000
Net Income Common Stockholders $-14,092,000 $-11,212,000 $-22,756,000 $-21,399,000
Net Income Including Noncontrolling Interests $-2,998,000 $-11,212,000 $-22,555,000 $-21,198,000
Net Income Continuous Operations $-2,998,000 $-11,212,000 $-22,555,000 $-21,198,000
Pretax Income $-2,991,000 $-11,994,000 $-25,551,000 $-25,915,000
Special Income Charges $4,947,000 $0 - -
Interest Income Non Operating $62,000 $12,000 $266,000 $210,000
Operating Income $-8,427,000 $-12,004,000 $-25,453,000 $-27,656,000
Gross Profit $138,000 $43,000 - -
Net Income - - - -
Per Share
Diluted EPS $-6.45 $-501.60 $-6420.00 $-6840.00
Basic EPS $-6.45 $-501.60 $-6420.00 $-6840.00
Other
Tax Effect Of Unusual Items $1,204,800 $-3,521 $-48,544 $42,410
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-13,442,000 $-11,944,000 $-25,008,000 $-27,857,000
Total Unusual Items $5,020,000 $-54,000 $-414,000 $233,000
Total Unusual Items Excluding Goodwill $5,020,000 $-54,000 $-414,000 $233,000
Reconciled Depreciation $5,000 $6,000 $31,000 $32,000
EBITDA (Bullshit earnings) $-8,422,000 $-11,998,000 $-25,422,000 $-27,624,000
EBIT $-8,427,000 $-12,004,000 $-25,453,000 $-27,656,000
Diluted Average Shares $2,185,075 $36,913 $3,545 $3,126
Basic Average Shares $2,185,075 $36,913 $3,545 $3,126
Diluted NI Availto Com Stockholders $-14,092,000 $-11,212,000 $-22,756,000 $-21,399,000
Otherunder Preferred Stock Dividend $11,033,000 $0 - $0
Preferred Stock Dividends $61,000 - $201,000 $201,000
Tax Provision $7,000 $-782,000 $-2,996,000 $-4,717,000
Gain On Sale Of Business $4,947,000 $0 - -
Gain On Sale Of Security $73,000 $-54,000 $-414,000 $233,000
Research And Development $848,000 $6,655,000 $19,155,000 $20,274,000
Selling General And Administration $7,717,000 $5,392,000 $6,718,000 $7,382,000
Other Gand A $7,717,000 $5,392,000 $6,718,000 $7,382,000
Fetched: 2026-06-12
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $5,272,000 $-2,174,000 $607,000 $20,433,000
Total Assets $8,185,000 $4,094,000 $8,805,000 $28,050,000
Total Non Current Assets $1,929,000 $419,000 $1,361,000 $3,639,000
Non Current Prepaid Assets $210,000 $412,000 $1,259,000 $3,465,000
Goodwill And Other Intangible Assets $1,570,000 $0 - -
Current Assets $6,256,000 $3,674,000 $7,444,000 $24,411,000
Other Current Assets $104,000 $325,000 $341,000 $426,000
Prepaid Assets $6,000 $212,000 - -
Inventory $1,384,000 $0 - -
Receivables $1,257,000 $0 $3,725,000 $5,640,000
Accounts Receivable $1,257,000 $0 - -
Allowance For Doubtful Accounts Receivable $-539,441 - - -
Gross Accounts Receivable $1,796,441 - - -
Cash Cash Equivalents And Short Term Investments $3,505,000 $3,137,000 $3,378,000 $18,345,000
Cash And Cash Equivalents $3,505,000 $3,137,000 $3,378,000 $18,345,000
Cash Equivalents $0 $3,044,000 $75,000 $4,547,000
Cash Financial $3,505,000 $93,000 $3,303,000 $13,798,000
Taxes Receivable - $237,000 $3,725,000 $5,640,000
Debt
Total Debt $2,000 $0 $37,000 $106,000
Long Term Debt And Capital Lease Obligation $2,000 $0 $37,000 $106,000
Liabilities
Total Liabilities Net Minority Interest $1,343,000 $6,268,000 $8,198,000 $7,617,000
Total Non Current Liabilities Net Minority Interest $11,000 $0 $37,000 $106,000
Other Non Current Liabilities $9,000 - - -
Current Liabilities $1,332,000 $6,268,000 $8,161,000 $7,511,000
Other Current Liabilities $215,000 $283,000 $380,000 $1,006,000
Payables And Accrued Expenses $1,117,000 $5,985,000 $7,781,000 $6,505,000
Payables $617,000 $4,599,000 $3,543,000 $2,561,000
Accounts Payable $617,000 $4,599,000 $3,543,000 $2,561,000
Equity
Common Stock Equity $6,842,000 $-2,174,000 $607,000 $20,433,000
Total Equity Gross Minority Interest $6,842,000 $-2,174,000 $607,000 $20,433,000
Stockholders Equity $6,842,000 $-2,174,000 $607,000 $20,433,000
Gains Losses Not Affecting Retained Earnings $-39,000 $-891,000 $-908,000 $-1,316,000
Other Equity Adjustments $-39,000 $-891,000 $-908,000 $-1,316,000
Retained Earnings $-454,411,000 $-439,494,000 $-428,282,000 $-405,727,000
Other
Preferred Shares Number $335,273 $335,273 $335,273 $335,273
Ordinary Shares Number $5,400,320 $36,913 $4,412 $3,483
Share Issued $5,400,320 $36,913 $4,412 $3,483
Tangible Book Value $5,272,000 $-2,174,000 $607,000 $20,433,000
Invested Capital $6,842,000 $-2,174,000 $607,000 $20,433,000
Working Capital $4,924,000 $-2,594,000 $-717,000 $16,900,000
Capital Lease Obligations $2,000 $0 $37,000 $106,000
Total Capitalization $6,842,000 $-2,174,000 $607,000 $20,433,000
Additional Paid In Capital $461,287,000 $438,211,000 $429,797,000 $422,981,000
Common Stock $5,000 $0 $0 $4,495,000
Preferred Stock $0 $0 $0 $0
Long Term Capital Lease Obligation $2,000 $0 $37,000 $106,000
Current Accrued Expenses $500,000 $1,386,000 $4,238,000 $3,944,000
Goodwill $1,570,000 $0 - -
Net PPE $149,000 $7,000 $102,000 $174,000
Accumulated Depreciation $-284,000 $-424,000 $-420,000 $-383,000
Gross PPE $433,000 $431,000 $522,000 $557,000
Leases $138,000 $6,000 $6,000 $6,000
Other Properties $12,000 $5,000 $93,000 $142,000
Machinery Furniture Equipment $283,000 $420,000 $423,000 $409,000
Properties $0 $0 $0 $0
Finished Goods $1,008,000 $0 - -
Work In Process $134,000 $0 - -
Raw Materials $242,000 $0 - -
Capital Stock - $0 $0 $4,495,000
Treasury Shares Number - - $0 -
Fetched: 2026-06-12
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-4,770,000 $-7,990,000 $-16,118,000 $-20,834,000
Operating Activities
Operating Cash Flow $-4,770,000 $-7,990,000 $-16,112,000 $-20,827,000
Cash Flow From Continuing Operating Activities $-4,770,000 $-7,990,000 $-16,112,000 $-20,827,000
Operating Gains Losses $4,947,000 - - -
Investing Activities
Investing Cash Flow $0 $0 $-6,000 $-7,000
Cash Flow From Continuing Investing Activities $0 $0 $-6,000 $-7,000
Capital Expenditure - - $-6,000 $-7,000
Financing Activities
Issuance Of Capital Stock $6,425,000 $6,209,000 $1,049,000 $3,199,000
Financing Cash Flow $5,264,000 $7,822,000 $848,000 $2,998,000
Cash Flow From Continuing Financing Activities $5,264,000 $7,822,000 $848,000 $2,998,000
Net Other Financing Charges $-1,100,000 - - -
Cash Dividends Paid $-61,000 $0 $-201,000 $-201,000
Preferred Stock Dividend Paid $-61,000 $0 $-201,000 $-201,000
Net Common Stock Issuance $6,425,000 $6,209,000 $1,049,000 $3,199,000
Common Stock Issuance $6,425,000 $6,209,000 $1,049,000 $3,199,000
Other
Interest Paid Supplemental Data $7,000 $0 - -
Income Tax Paid Supplemental Data $18,000 $2,000 $2,000 $2,000
End Cash Position $3,505,000 $3,137,000 $3,378,000 $18,345,000
Beginning Cash Position $3,137,000 $3,378,000 $18,345,000 $36,559,000
Effect Of Exchange Rate Changes $-126,000 $-73,000 $303,000 $-378,000
Changes In Cash $494,000 $-168,000 $-15,270,000 $-17,836,000
Proceeds From Stock Option Exercised $0 $1,613,000 $0 $0
Net PPE Purchase And Sale $0 $0 $-6,000 $-7,000
Purchase Of PPE $0 $0 $-6,000 $-7,000
Change In Working Capital $-9,060,000 $2,661,000 $5,008,000 $-1,167,000
Change In Payables And Accrued Expense $-10,506,000 $-1,811,000 $296,000 $2,577,000
Change In Payable $-10,506,000 $-1,811,000 $296,000 $2,577,000
Change In Account Payable $-10,506,000 $-1,811,000 $296,000 $2,577,000
Change In Prepaid Assets $4,087,000 $4,472,000 $4,712,000 $-3,784,000
Change In Inventory $-1,384,000 $0 - -
Change In Receivables $-1,257,000 $0 - -
Changes In Account Receivables $-1,257,000 $0 - -
Other Non Cash Items $2,000 $-37,000 $-69,000 -
Stock Based Compensation $2,334,000 $592,000 $1,473,000 $1,506,000
Depreciation Amortization Depletion $5,000 $6,000 $31,000 $32,000
Depreciation And Amortization $5,000 $6,000 $31,000 $32,000
Depreciation $5,000 $6,000 $31,000 $32,000
Gain Loss On Sale Of Business $4,947,000 $0 - -
Net Income From Continuing Operations $-2,998,000 $-11,212,000 $-22,555,000 $-21,198,000
Change In Other Current Liabilities - $-37,000 $-69,000 $40,000
Fetched: 2026-06-12